<VariationArchive VariationID="1213917" VariationName="NM_000329.3(RPE65):c.859del" VariationType="Deletion" Accession="VCV001213917" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-03-11" DateCreated="2021-09-08" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1203910" VariationID="1213917">
      <GeneList>
        <Gene Symbol="RPE65" FullName="retinoid isomerohydrolase RPE65" GeneID="6121" HGNC_ID="HGNC:10294" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="68428822" stop="68449954" display_start="68428822" display_stop="68449954" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="68894506" stop="68915641" display_start="68894506" display_stop="68915641" Strand="-" />
          </Location>
          <OMIM>180069</OMIM>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000329.3(RPE65):c.859del</Name>
      <CanonicalSPDI>NC_000001.11:68439080:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p31.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="68904764" stop="68904764" display_start="68904764" display_stop="68904764" variantLength="1" positionVCF="68904763" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="68439081" stop="68439081" display_start="68439081" display_stop="68439081" variantLength="1" positionVCF="68439080" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000329.3" sequenceAccession="NM_000329" sequenceVersion="3" change="c.859del" MANESelect="true">
            <Expression>NM_000329.3:c.859del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.68904765del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.68904765del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.68439082del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.68439082del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008472.2" sequenceAccession="NG_008472" sequenceVersion="2" change="g.15879del">
            <Expression>NG_008472.2:g.15879del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2100818777" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000329.3(RPE65):c.859del AND Leber congenital amaurosis 2" Accession="RCV001591859" Version="1">
        <ClassifiedConditionList TraitSetID="3569">
          <ClassifiedCondition DB="MedGen" ID="C1859844">Leber congenital amaurosis 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-06-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000329.3(RPE65):c.859del AND RPE65-related recessive retinopathy" Accession="RCV003771782" Version="1">
        <ClassifiedConditionList TraitSetID="81319">
          <ClassifiedCondition DB="MedGen" ID="CN305526">RPE65-related recessive retinopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2024-02-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-20" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2021-09-08" MostRecentSubmission="2024-02-28">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/2513f264-dcac-4500-a13c-32e471b9028d</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="3569" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5384" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">RPE65-Related Leber Congenital Amaurosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Leber congenital amaurosis 2</ElementValue>
                <XRef ID="Leber+congenital+amaurosis+type+2/4136" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008765" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">AMAUROSIS CONGENITA OF LEBER II</ElementValue>
                <XRef Type="MIM" ID="204100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Amaurosis congenita of Leber, type 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LCA2</ElementValue>
                <XRef Type="MIM" ID="204100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000518813" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500417" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501118" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506299" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553865" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502495" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="636" />
                <XRef ID="636" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">RPE65-related Leber congenital amaurosis / early-onset severe retinal dystrophy (RPE65-LCA/EOSRD) is a severe inherited retinal degeneration (IRD) with a typical presentation between birth and age five years. While central vision varies, the hallmark of this disorder is the presence of severe visual impairment with a deceptively preserved retinal structure. Vision is relatively stable in the first decade of life, but begins to decline in adolescence. Most affected individuals are legally blind (visual acuity 20/200 and/or visual fields extending &lt;20 degrees from fixation) by age 20 years. After age 20 years, visual acuity declines further and by the fourth decade all affected individuals are legally blind and many have complete loss of vision (i.e., no light perception). Milder disease phenotypes have been described in individuals with hypomorphic alleles.</Attribute>
                <XRef ID="NBK549574" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">30285347</ID>
                <ID Source="BookShelf">NBK531510</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31725251</ID>
                <ID Source="BookShelf">NBK549574</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="65" DB="Orphanet" />
              <XRef ID="C1859844" DB="MedGen" />
              <XRef ID="MONDO:0008765" DB="MONDO" />
              <XRef Type="MIM" ID="204100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="81319" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="61324" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">RPE65-related recessive retinopathy</ElementValue>
                <XRef ID="MONDO:0100368" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Recessive RPE65 retinopathy</ElementValue>
              </Name>
              <XRef ID="CN305526" DB="MedGen" />
              <XRef ID="MONDO:0100368" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3557060" SubmissionDate="2021-07-23" DateLastUpdated="2021-09-08" DateCreated="2021-09-08">
        <ClinVarSubmissionID localKey="NM_000329.3:c.859del|OMIM:204100" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001815981" DateUpdated="2021-09-08" DateCreated="2021-09-08" Type="SCV" Version="1" SubmitterName="DBGen Ocular Genomics" OrgID="508130" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>unspecified</Ethnicity>
              <GeographicOrigin>Spain</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPE65" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000329.3:c.859del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="204100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10063720</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="8652808" SubmissionDate="2024-02-20" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="2513f264-dcac-4500-a13c-32e471b9028d" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004697396" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="ClinGen Leber Congenital Amaurosis/early Onset Retinal Dystrophy Variant Curation Expert Panel, ClinGen" OrgID="509356" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-20">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/2513f264-dcac-4500-a13c-32e471b9028d</URL>
          </Citation>
          <Comment>NM_000329.3(RPE65):c.859delG (p.Val287PhefsTer38) is a frameshift variant that introduces a premature stop codon into exon 9 of 14, and is predicted to lead to nonsense-mediated decay in a gene in which loss-of-function is an established mechanism of disease (PVS1). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). At least one proband harboring this variant exhibits a phenotype including a clinical diagnosis of Leber congenital amaurosis (0.5 pts), loss of visual acuity (1 pt) since age 1 year (1 pt), nystagmus (1 pt), night blindness (0.5 pts), pigmentary retinopathy with attenuated vessels (0.5 pts), and pale optic disc (0.5 pts), which together are specific for RPE65-related recessive retinopathy (5 points, PMID: 34492281, PP4). The variant has been reported to segregate with childhood-onset severe retinal dystrophy through the proband plus 2 similarly affected relatives, with the variant present in the compound heterozygous state (PMID: 34492281, PP1_moderate). In summary, this variant meets the criteria to be classified as pathogenic for RPE65-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA / eoRD VCEP: PVS1, PM2_supporting, and PP1_moderate. (VCEP specifications version 1.0.0; date of approval 09/21/2023).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen LCAeoRD ACMG Specifications RPE65 V1.0.0</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/f0jffitz/clingen_lcaeord_acmg_specifications_rpe65_v1.0.0.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPE65" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000329.3(RPE65):c.859del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.11:g.68439082del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0100368" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14259585</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3557060" TraitType="Disease" MappingType="XRef" MappingValue="204100" MappingRef="OMIM">
        <MedGen CUI="C1859844" Name="Leber congenital amaurosis 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8652808" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0100368" MappingRef="MONDO">
        <MedGen CUI="CN305526" Name="RPE65-related recessive retinopathy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

